Published in Int J Radiat Oncol Biol Phys on May 01, 2008
Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol (2011) 2.05
Dosimetric and radiobiological characterizations of prostate intensity-modulated radiotherapy and volumetric-modulated arc therapy: A single-institution review of ninety cases. J Med Phys (2016) 1.38
Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy. Radiat Oncol (2009) 1.29
Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer. Radiat Oncol (2010) 1.25
Evaluation of volumetric modulated arc therapy (VMAT) with Oncentra MasterPlan® for the treatment of head and neck cancer. Radiat Oncol (2010) 1.21
A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys (2012) 1.19
Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol (2011) 1.14
A study on conventional IMRT and RapidArc treatment planning techniques for head and neck cancers. Rep Pract Oncol Radiother (2012) 1.07
Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy. Radiat Oncol (2010) 1.06
Comparison of prostate IMRT and VMAT biologically optimised treatment plans. Med Dosim (2010) 1.06
RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study. Radiat Oncol (2009) 1.04
A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT). Radiat Oncol (2009) 1.02
Impact of gantry rotation time on plan quality and dosimetric verification--volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT). Strahlenther Onkol (2011) 1.00
Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy? Int J Radiat Oncol Biol Phys (2012) 0.98
Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study. J Radiat Res (2012) 0.96
In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors. Radiat Meas (2012) 0.95
Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and/or lymph node involvement. Br J Radiol (2011) 0.95
Radiobiological impact of planning techniques for prostate cancer in terms of tumor control probability and normal tissue complication probability. Ann Med Health Sci Res (2014) 0.94
A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol (2010) 0.93
Current and future treatments for hepatocellular carcinoma. World J Gastroenterol (2015) 0.92
RapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: a treatment planning comparison with fixed field IMRT. J Radiat Res (2012) 0.89
RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study. Br J Radiol (2012) 0.88
Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma. Radiat Oncol J (2015) 0.87
Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy. Br J Radiol (2013) 0.87
A retrospective planning analysis comparing intensity modulated radiation therapy (IMRT) to volumetric modulated arc therapy (VMAT) using two optimization algorithms for the treatment of early-stage prostate cancer. J Med Radiat Sci (2013) 0.86
Is RapidArc more susceptible to delivery uncertainties than dynamic IMRT? Med Phys (2012) 0.85
A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer. Radiat Oncol (2012) 0.85
Whole abdomen radiation therapy in ovarian cancers: a comparison between fixed beam and volumetric arc based intensity modulation. Radiat Oncol (2010) 0.84
A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse. Radiat Oncol (2014) 0.84
Toxicity outcome in patients treated with modulated arc radiotherapy for localized prostate cancer. Rep Pract Oncol Radiother (2013) 0.84
Target tracking using DMLC for volumetric modulated arc therapy: a simulation study. Med Phys (2010) 0.84
Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation. Front Oncol (2016) 0.83
Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer. Radiat Oncol (2012) 0.83
Feasibility study of volumetric modulated arc therapy for the treatment of retroperitoneal sarcomas. Radiat Oncol (2010) 0.83
Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment. Radiat Oncol (2010) 0.83
Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy. Br J Radiol (2013) 0.82
A dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer. Radiat Oncol (2014) 0.82
Comparison of dosimetric variation between prostate IMRT and VMAT due to patient's weight loss: Patient and phantom study. Rep Pract Oncol Radiother (2013) 0.81
Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF. Strahlenther Onkol (2011) 0.80
Comparing four volumetric modulated arc therapy beam arrangements for the treatment of early-stage prostate cancer. J Med Radiat Sci (2014) 0.80
A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer. Br J Radiol (2013) 0.80
Clinical utility of RapidArc™ radiotherapy technology. Cancer Manag Res (2015) 0.80
Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT). Radiother Oncol (2013) 0.79
Optimal partial-arcs in VMAT treatment planning. Phys Med Biol (2012) 0.79
Influence of segment width on plan quality for volumetric modulated arc based stereotactic body radiotherapy. Rep Pract Oncol Radiother (2014) 0.79
Multicriteria optimization informed VMAT planning. Med Dosim (2013) 0.79
Retrospective evaluation of dosimetric quality for prostate carcinomas treated with 3D conformal, intensity modulated and volumetric modulated arc radiotherapy. J Med Radiat Sci (2013) 0.79
Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer. J Radiat Res (2014) 0.79
Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer. Radiat Oncol (2015) 0.79
Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity. J Radiat Res (2014) 0.78
Dosimetric comparison for volumetric modulated arc therapy and intensity-modulated radiotherapy on the left-sided chest wall and internal mammary nodes irradiation in treating post-mastectomy breast cancer. Radiol Oncol (2015) 0.78
Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001). Int J Radiat Oncol Biol Phys (2009) 0.78
Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment. Chin J Cancer (2013) 0.78
Comparison of two different IMRT planning techniques in the treatment of nasopharyngeal carcinoma. Effect on parotid gland radiation doses. Strahlenther Onkol (2013) 0.78
SmartArc-based volumetric modulated arc therapy for endometrial cancer: a dosimetric comparison with helical tomotherapy and intensity-modulated radiation therapy. BMC Cancer (2013) 0.78
Dosimetric effects of the acuros XB and anisotropic analytical algorithm on volumetric modulated arc therapy planning for prostate cancer using an endorectal balloon. Radiat Oncol (2015) 0.77
Feasibility of constant dose rate VMAT in the treatment of nasopharyngeal cancer patients. Radiat Oncol (2014) 0.77
Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancer. Phys Med Biol (2012) 0.77
Is there room for combined modality treatments? Dosimetric comparison of boost strategies for advanced head and neck and prostate cancer. J Radiat Res (2013) 0.77
The dosimetric impact of different photon beam energy on RapidArc radiotherapy planning for cervix carcinoma. J Med Phys (2016) 0.77
Peripheral dose measurements in cervical cancer radiotherapy: a comparison of volumetric modulated arc therapy and step-and-shoot IMRT techniques. Radiat Oncol (2014) 0.77
mARC vs. IMRT radiotherapy of the prostate with flat and flattening-filter-free beam energies. Radiat Oncol (2014) 0.77
Risk-adaptive volumetric modulated arc therapy using biological objective functions for subvolume boosting in radiotherapy. Comput Math Methods Med (2012) 0.77
Chest wall desmoid tumours treated with definitive radiotherapy: a plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy. Radiat Oncol (2016) 0.76
Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancer. Radiat Oncol J (2013) 0.75
Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays. J Radiat Res (2015) 0.75
Implementation of Constant Dose Rate and Constant Angular Spacing Intensity-modulated Arc Therapy for Cervical Cancer by Using a Conventional Linear Accelerator. Chin Med J (Engl) (2016) 0.75
Metabolic syndrome-related hepatocellular carcinoma treated by volumetric modulated arc therapy. Curr Oncol (2014) 0.75
Dosimetric comparison of intensity-modulated radiation therapy and volumetric-modulated arc therapy plans for the treatment of glioma using flattening filter-free and flattening filter modes. Oncol Lett (2017) 0.75
The dosimetric significance of using 10 MV photons for volumetric modulated arc therapy for post-prostatectomy irradiation of the prostate bed. Radiol Oncol (2016) 0.75
Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know? Biomed Res Int (2016) 0.75
A hybrid IMRT/VMAT technique for the treatment of nasopharyngeal cancer. Biomed Res Int (2015) 0.75
Analyzing the performance of ArcCHECK diode array detector for VMAT plan. Rep Pract Oncol Radiother (2015) 0.75
Volumetric-modulated arc therapy for oropharyngeal carcinoma: a dosimetric and delivery efficiency comparison with static-field IMRT. Phys Med (2014) 0.75
A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys (2015) 0.75
Relationship between prostate volume changes and treatment duration of neoadjuvant androgen deprivation during intensity-modulated radiation therapy for Japanese patients with prostate cancer. Nagoya J Med Sci (2016) 0.75
Volumetric Modulated Arc Therapy of the Pelvic Lymph Nodes to the Aortic Bifurcation in Higher Risk Prostate Cancer: Early Toxicity Outcomes. Biomed Res Int (2015) 0.75
Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids. Br J Radiol (2015) 0.75
Use of plan quality degradation to evaluate tradeoffs in delivery efficiency and clinical plan metrics arising from IMRT optimizer and sequencer compromises. Med Phys (2013) 0.75
Comparison of Rapid Arc and Intensity-modulated Radiotherapy Plans Using Unified Dosimetry Index and the Impact of Conformity Index on Unified Dosimetry Index Evaluation. J Med Phys (2017) 0.75
A comparative dosimetric study of volumetric-modulated arc therapy vs. fixed field intensity-modulated radiotherapy in postoperative irradiation of stage IB-IIA high-risk cervical cancer. Oncol Lett (2015) 0.75
A treatment planning study comparing tomotherapy, volumetric modulated arc therapy, Sliding Window and proton therapy for low-risk prostate carcinoma. Radiat Oncol (2016) 0.75
Comparison of hybrid volumetric modulated arc therapy (VMAT) technique and double arc VMAT technique in the treatment of prostate cancer. Radiol Oncol (2015) 0.75
Efficiency gains for spinal radiosurgery using multicriteria optimization intensity modulated radiation therapy guided volumetric modulated arc therapy planning. Pract Radiat Oncol (2014) 0.75
Volumetric modulated arc therapy for treatment of solid tumors: current insights. Onco Targets Ther (2017) 0.75
A systematic survey of loss-of-function variants in human protein-coding genes. Science (2012) 12.25
Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys (2010) 2.66
Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys (2010) 2.48
Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys (2010) 2.08
Mechanical ventilation results in progressive contractile dysfunction in the diaphragm. J Appl Physiol (1985) (2002) 1.89
MicroRNAs associated with metastatic prostate cancer. PLoS One (2011) 1.66
A family of ductile intermetallic compounds. Nat Mater (2003) 1.66
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development. Cancer Res (2013) 1.58
The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys (2012) 1.46
Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys (2009) 1.30
A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys (2009) 1.25
Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration. Mol Ther (2010) 1.22
Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys (2008) 1.19
New developments in arc radiation therapy: a review. Cancer Treat Rev (2010) 1.19
Diaphragm unloading via controlled mechanical ventilation alters the gene expression profile. Am J Respir Crit Care Med (2005) 1.17
Parasitic exploitation as an engine of diversity. Biol Rev Camb Philos Soc (2003) 1.14
Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys (2004) 1.05
3D needle-tissue interaction simulation for prostate brachytherapy. Med Image Comput Comput Assist Interv (2005) 1.03
Use of computed tomography imaging for quantifying coarse roots, rhizomes, peat, and particle densities in marsh soils. Ecol Appl (2011) 1.02
Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Support Care Cancer (2008) 1.01
Letter to the Editor on 'Single-Arc IMRT?'. Phys Med Biol (2009) 0.99
Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients. Clin Cancer Res (2009) 0.99
Rectal toxicity and rectal dosimetry in low-dose-rate (125)I permanent prostate implants: a long-term study in 1006 patients. Brachytherapy (2011) 0.98
Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model. Acta Oncol (2010) 0.98
Direct aperture optimization for IMRT using Monte Carlo generated beamlets. Med Phys (2006) 0.98
Transposon mutagenesis of Trypanosoma brucei identifies glycosylation mutants resistant to concanavalin A. J Biol Chem (2004) 0.95
Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys (2008) 0.95
Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size. J Clin Oncol (2008) 0.94
Tracking Medicaid managed care in rural communities: a fifty-state follow-up. Health Aff (Millwood) (2002) 0.93
Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer (2014) 0.92
Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys (2012) 0.92
Decline in urinary retention incidence in 805 patients after prostate brachytherapy: the effect of learning curve? Int J Radiat Oncol Biol Phys (2006) 0.92
Microwave-accelerated iridium-catalyzed borylation of aromatic C-H bonds. Org Lett (2009) 0.90
Investigation of a novel algorithm for true 4D-VMAT planning with comparison to tracked, gated and static delivery. Med Phys (2011) 0.90
Finding needles (or ants) in haystacks: predicting locations of invasive organisms to inform eradication and containment. Ecol Appl (2010) 0.90
Novel N-aryl and N-heteroaryl sulfamide synthesis via palladium cross coupling. Org Lett (2004) 0.89
Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy. Cancer (2010) 0.89
Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer. Cancer (2012) 0.88
The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys (2003) 0.87
Severe dry eye syndrome after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys (2011) 0.86
Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom. Eur J Health Econ (2005) 0.86
A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors. Pediatr Blood Cancer (2010) 0.85
Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions. Radiother Oncol (2013) 0.85
Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the phoenix definition of biochemical failure. Int J Radiat Oncol Biol Phys (2010) 0.85
Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy. Acad Radiol (2005) 0.85
Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life. J Neurooncol (2011) 0.85
Prostate brachytherapy postimplant dosimetry: a comparison of prostate quadrants. Int J Radiat Oncol Biol Phys (2002) 0.84
Direct aperture optimization for online adaptive radiation therapy. Med Phys (2007) 0.84
Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases. Support Care Cancer (2010) 0.84
Epidemiologic modeling with FluSurge for pandemic (H1N1) 2009 outbreak, Queensland, Australia. Emerg Infect Dis (2011) 0.83
Condom use behaviours and correlates of use in the Botswana Defence Force. Int J STD AIDS (2013) 0.83
Assessment of behavioral mechanisms maintaining encopresis: Virginia Encopresis-Constipation Apperception Test. J Pediatr Psychol (2003) 0.83
Pretreatment PSA velocity as a predictor of disease outcome following radical radiation therapy. Int J Radiat Oncol Biol Phys (2007) 0.83
Factors predictive of symptomatic radiation injury after linear accelerator-based stereotactic radiosurgery for intracerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys (2011) 0.82
How prostate cancer support groups do and do not survive: British Columbian perspectives. Am J Mens Health (2007) 0.81
Selection bias introduced by neuropsychological assessments. Can J Neurol Sci (2010) 0.81
Does intensity modulation improve healthy tissue sparing in stereotactic radiosurgery of complex arteriovenous malformations? Med Dosim (2007) 0.81
Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002. Urology (2006) 0.81
Integration of on-line imaging, plan adaptation and radiation delivery: proof of concept using digital tomosynthesis. Phys Med Biol (2009) 0.81
Dose-distance metric that predicts late rectal bleeding in patients receiving radical prostate external-beam radiotherapy. Phys Med Biol (2012) 0.81
Optimization of stereotactic radiotherapy treatment delivery technique for base-of-skull meningiomas. Med Dosim (2008) 0.81
The use of film dosimetry of the penumbra region to improve the accuracy of intensity modulated radiotherapy. Med Phys (2005) 0.80
Radiosurgery scope of practice in Canada: a report of the Canadian association of radiation oncology (CARO) radiosurgery advisory committee. Radiother Oncol (2010) 0.80
Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis. Value Health (2011) 0.79
Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy. Brachytherapy (2010) 0.79
Biological consequences of MLC calibration errors in IMRT delivery and QA. Med Phys (2012) 0.78
HIV seroprevalence, associated risk behavior, and alcohol use among male Rwanda Defense Forces military personnel. AIDS Behav (2013) 0.78
Maximizing the potential of direct aperture optimization through collimator rotation. Med Phys (2007) 0.78
Prevalence of PTSD and depression, and associated sexual risk factors, among male Rwanda Defense Forces military personnel. Trop Med Int Health (2013) 0.78
Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations. Mov Disord (2014) 0.78
Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy. Radiother Oncol (2013) 0.78
Secondary effects of femoral instrumentation on pulmonary physiology in a standardised sheep model: what is the effect of lung contusion and reaming? Injury (2005) 0.78
Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. Radiother Oncol (2005) 0.78
Comparisons of reported sexual behaviors from a retrospective survey versus a prospective diary in the Botswana Defence Force. AIDS Educ Prev (2013) 0.78
Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. J Neurosurg (2007) 0.78
Restoration of topoisomerase 2 function by complementation of defective monomers in Drosophila. Genetics (2012) 0.78
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers. Int J Radiat Oncol Biol Phys (2013) 0.78
Evaluation of dosimetric consequences of seroma contour variability in accelerated partial breast irradiation using a constructed representative seroma contour. Int J Radiat Oncol Biol Phys (2012) 0.77
Equivalent doses for gynecological patients undergoing IMRT or RapidArc with kilovoltage cone beam CT. Radiother Oncol (2012) 0.77
Opinion formation in evaluating the adjudicative competence and restorability of criminal defendants: a review of 8,000 evaluations. Behav Sci Law (2006) 0.77
Audiologic and treatment outcomes after linear accelerator-based stereotactic irradiation for acoustic neuroma. Int J Radiat Oncol Biol Phys (2004) 0.77
The effect of loose versus stranded seeds on biochemical no evidence of disease in patients with carcinoma of the prostate treated with iodine-125 brachytherapy. Brachytherapy (2011) 0.77
Long-term outcomes of fractionated stereotactic radiation therapy for pituitary adenomas at the BC Cancer Agency. Int J Radiat Oncol Biol Phys (2013) 0.77
Assessing deaf awareness training: knowledge and attitudes of recent genetic counseling graduates. J Genet Couns (2014) 0.77
An anthropomorphic phantom study of visualisation of surgical clips for partial breast irradiation (PBI) setup verification. Radiother Oncol (2008) 0.77